GlassScriptPhysician profile
Jeffrey S Marshick
NPI 1811013865
$16,079.02
in general payments reported to CMS, 2019-2025
51 companies · $2,692 in 2025
The $2,692 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,296 · 2020: $1,852 · 2021: $2,123 · 2022: $2,116 · 2023: $2,669 · 2024: $2,331 · 2025: $2,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,612 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,611.92 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,573.04 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,209.38 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $1,870.05 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Harmony Biosciences LLC | $1,097.67 | 2020-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $1,050.56 | 2020-2025 | Glassia |
| Mylan Specialty L.P. | $801.50 | 2019-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $685.85 | 2019-2025 | Xywav |
| Grifols USA, LLC | $577.81 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $528.28 | 2019-2025 | Dupixent |
| Genzyme Corporation | $415.12 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $291.45 | 2019-2020 | |
| United Therapeutics Corporation | $290.17 | 2020-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $262.06 | 2021-2025 | Arikayce, Brinsupri |
| Axsome Therapeutics, INC. | $252.21 | 2023-2025 | Sunosi |
| Pulmonx Corporation | $235.81 | 2020-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $217.03 | 2019-2025 | Smartvest |
| Philips North America LLC | $190.77 | 2019-2025 | Vest Therapy Und |
| Actelion Pharmaceuticals US, INC. | $163.03 | 2019-2025 | Uptravi, Opsumit |
| Teva Pharmaceuticals USA, INC. | $156.93 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $143.83 | 2019-2023 | Ultomiris |
| Mallinckrodt Hospital Products INC. | $141.89 | 2020-2022 | |
| Genentech USA, INC. | $136.18 | 2019-2023 | Xolair |
| Merck Sharp & Dohme LLC | $124.43 | 2022-2025 | Keytruda, Zerbaxa, Recarbrio |
| Circassia INC. | $123.47 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $117.25 | 2023-2025 | Purified Cortrophin Gel |
| Mallinckrodt Enterprises LLC | $112.07 | 2019 | |
| Arbor Pharmaceuticals, INC. | $111.41 | 2020-2022 | |
| Viatris Specialty LLC | $107.12 | 2025 | Yupelri |
| Amgen INC. | $101.08 | 2022-2024 | Tezspire |
| Shire North American Group INC | $100.82 | 2019 | |
| Resmed Corp | $95.37 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $85.04 | 2019-2025 | |
| Azurity Pharmaceuticals, INC. | $81.82 | 2024 | Horizant |
| Baxter Healthcare | $72.93 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Paratek Pharmaceuticals, INC. | $65.14 | 2023-2025 | Nuzyra |
| Advanced Respiratory, INC | $57.55 | 2020-2021 | |
| Inspire Medical Systems, INC. | $57.47 | 2023-2024 | Inspire |
| Abbvie INC. | $55.14 | 2022-2023 | |
| Avadel Cns Pharmaceuticals, LLC | $47.73 | 2023-2024 | Lumryz |
| Inogen, INC. | $43.43 | 2022-2023 | Inogen |
| Pharming Healthcare, INC. | $32.74 | 2024 | Ruconest |
| Csl Behring | $30.85 | 2019 | |
| Itamar Medical INC | $24.97 | 2024 | Watchpatone |
| Hikma Pharmaceuticals USA | $19.75 | 2023 | Ryaltris |
| Nabriva Therapeutics, Plc | $19.68 | 2021 | |
| Verona Pharma, INC. | $19.37 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $18.54 | 2020 | |
| La Jolla Pharmaceutical Company | $17.60 | 2019 | |
| Covis Pharma Gmbh | $17.21 | 2023 | |
| Pfizer INC. | $14.92 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Marshick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.